Literature DB >> 20964488

Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden.

Torbjörn Ramqvist1, Juan Du, Mikaela Lundén, Sofie Ahrlund-Richter, Joana Ferreira, Lena Marions, Pär Sparén, Sören Andersson, Tina Dalianis.   

Abstract

Knowledge of the prevalence of different human papillomavirus (HPV) types in young girls is important for the early detection of changes in HPV prevalence, e.g. due to HPV vaccines. The purpose of this study was to obtain information on the prevalence of 24 different genital HPV types in a group of sexually active young women (aged 15-23 y) attending a major youth healthcare centre in Stockholm, before the introduction of public HPV vaccination of young women in the autumn of 2010. A total of 615 women were analyzed for 24 different, mainly high-risk HPV (HR-HPV) types using multiplex polymerase chain reaction and Luminex technology. A high HPV prevalence in this cohort was demonstrated, particularly with regard to HPV16, but also to all included HR-HPV types. Of the 544 successfully analyzed samples from non-vaccinated individuals, 70% were positive for the HPV types assayed for, and 62% were positive for HR-HPV types. Over a third (34.7%) of the women were infected with HPV16, and a high frequency of infections with HR-HPV types 51 (10.7%), 18 (10.1%), 52 (9.9%) and 73 (9.4%) was also observed. At least 9 different non-vaccine HR-HPV types were present with a prevalence of >6% in this selected group of young women.

Entities:  

Mesh:

Year:  2010        PMID: 20964488     DOI: 10.3109/00365548.2010.526957

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Prevalence of oral human papillomavirus infection among youth, Sweden.

Authors:  Juan Du; Cecilia Nordfors; Andreas Ahrlund-Richter; Michal Sobkowiak; Mircea Romanitan; Anders Näsman; Sören Andersson; Torbjörn Ramqvist; Tina Dalianis
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

2.  Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden.

Authors:  Juan Du; Cecilia Nordfors; Anders Näsman; Michal Sobkowiak; Mircea Romanitan; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.

Authors:  Anders Näsman; Cecilia Nordfors; Nathalie Grün; Eva Munck-Wikland; Torbjörn Ramqvist; Linda Marklund; David Lindquist; Tina Dalianis
Journal:  Cancer Med       Date:  2013-06-14       Impact factor: 4.452

4.  Paediatric virology and human papillomaviruses: An update.

Authors:  Ioannis N Mammas; Tina Dalianis; Sotiros G Doukas; Apostolos Zaravinos; Vassilis Achtsidis; Prakash Thiagarajan; Maria Theodoridou; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2019-04-22       Impact factor: 2.447

5.  Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.

Authors:  Andreas Ährlund-Richter; Liqin Cheng; Yue O O Hu; Mikaela Svensson; Alexandra A L Pennhag; Ramona G Ursu; Linnea Haeggblom; Nathalie Grün; Torbjörn Ramqvist; Lars Engstrand; Tina Dalianis; Juan Du
Journal:  Front Cell Infect Microbiol       Date:  2019-03-20       Impact factor: 5.293

6.  Vaginal microbiota and human papillomavirus infection among young Swedish women.

Authors:  Liqin Cheng; Johanna Norenhag; Yue O O Hu; Nele Brusselaers; Emma Fransson; Andreas Ährlund-Richter; Unnur Guðnadóttir; Pia Angelidou; Yinghua Zha; Marica Hamsten; Ina Schuppe-Koistinen; Matts Olovsson; Lars Engstrand; Juan Du
Journal:  NPJ Biofilms Microbiomes       Date:  2020-10-12       Impact factor: 7.290

7.  Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour.

Authors:  Hedvig E Löfdahl; Juan Du; Anders Näsman; Emilia Andersson; Carlos A Rubio; Yunxia Lu; Torbjörn Ramqvist; Tina Dalianis; Jesper Lagergren; Hanna Dahlstrand
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

8.  HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome.

Authors:  Anders Näsman; Emilia Andersson; Linda Marklund; Nikolaos Tertipis; Lalle Hammarstedt-Nordenvall; Per Attner; Tommy Nyberg; Giuseppe V Masucci; Eva Munck-Wikland; Torbjörn Ramqvist; Tina Dalianis
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

9.  Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia.

Authors:  Marianela Patzi-Churqui; Katty Terrazas-Aranda; Jan-Åke Liljeqvist; Magnus Lindh; Kristina Eriksson
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.